Soligenix
SNGX
#10791
Rank
A$7.7 M
Marketcap
A$0.52
Share price
1.59%
Change (1 day)
-75.58%
Change (1 year)

Earnings for Soligenix (SNGX)

Earnings in 2025 (TTM): -A$19.38 Million

According to Soligenix's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -A$13.36 Million a decrease over its 2023 earnings that were of -A$10.86 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Soligenix from 1998 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$19.38 Million45.15%
2024 -A$13.36 Million22.96%
2023 -A$10.86 Million-45.74%
2022 -A$20.02 Million11.88%
2021 -A$17.89 Million-32.37%
2020 -A$26.45 Million83.18%
2019 -A$14.44 Million11.57%
2018 -A$12.94 Million19.29%
2017 -A$10.85 Million33%
2016 -A$8.16 Million-19.7%
2015 -A$10.16 Million5.16%
2014 -A$9.66 Million
2010 -A$10.91 Million26.12%
2009 -A$8.65 Million75.1%
2008 -A$4.94 Million-45.38%
2007 -A$9.04 Million-22.84%
2006 -A$11.72 Million66.15%
2005 -A$7.05 Million-16.65%
2004 -A$8.46 Million13.28%
2003 -A$7.47 Million-11.88%
2002 -A$8.48 Million-59.44%
2001 -A$20.89 Million378.18%
2000 -A$4.37 Million-38.53%
1999 -A$7.11 Million-18.43%
1998 -A$8.72 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$37.10 B-210,134.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$15.12 B-85,726.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$10.93 B-62,017.23%๐Ÿ‡ซ๐Ÿ‡ท France
Onconova Therapeutics
ONTX
-A$25.94 Million 46.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
-A$59.65 Million 237.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
A$3.24 B-18,460.57%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Cleveland BioLabs
CBLI
-A$3.94 Million-77.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
A$0.23 B-1,436.42%๐Ÿ‡บ๐Ÿ‡ธ USA